Search

Search Constraints

You searched for: Author/Creator Willekens, Barbara

Search Results

1. Altered molecular expression of TLR-signaling pathways affects the steady-state release of IL-12p70 and IFN-α in patients with relapsing-remitting multiple sclerosis. Issue 4 (May 2016)

2. Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors. (April 2014)

4. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022)

5. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis. (June 2023)

6. Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial. (November 2019)

7. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease. (5th October 2021)

8. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease. (5th October 2021)

9. Immunomodulatory Effects of 1, 25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens. (14th September 2016)